Sciences Get Rating News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sciences get rating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sciences Get Rating Today - Breaking & Trending Today

Contrasting Viridian Therapeutics (NASDAQ:VRDN) & Exact Sciences (NASDAQ:EXAS)

Viridian Therapeutics (NASDAQ:VRDN – Get Rating) and Exact Sciences (NASDAQ:EXAS – Get Rating) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, valuation, dividends and profitability. Volatility & Risk Viridian Therapeutics has a beta of 1.13, […] ....

United States , Sciences Get Rating , Foundation For Medical Education , Miragen Therapeutics Inc , Hologic Inc , Viridian Therapeutics Inc , Sciences Corporation , Viridian Therapeutics , Get Rating , Exact Sciences , Exact Science , Given Viridian Therapeutic , Miragen Therapeutics , Oncotype Test , Detect Test , Oncomap Extra , Medical Education , Exact Sciences Corporation , Nasdaq Vrdn , Stock Comparison , Stock Analysis ,

Genetron (NASDAQ:GTH) and Exact Sciences (NASDAQ:EXAS) Head-To-Head Analysis

Exact Sciences (NASDAQ:EXAS – Get Rating) and Genetron (NASDAQ:GTH – Get Rating) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings. Institutional and Insider Ownership 94.5% of Exact Sciences shares are held […] ....

United States , Onco Panscan , Genetron Holdings , Sciences Get Rating , Foundation For Medical Education , Hologic Inc , Sciences Corporation , Jd Health , Exact Sciences , Get Rating , Given Genetron , Oncotype Test , Detect Test , Oncomap Extra , Medical Education , Exact Sciences Corporation , Holdings Limited , Genetron Chef System , Nasdaq Exas , Stock Comparison , Stock Analysis ,

Reviewing PotNetwork (OTCMKTS:POTN) and Exact Sciences (NASDAQ:EXAS)

PotNetwork (OTCMKTS:POTN – Get Rating) and Exact Sciences (NASDAQ:EXAS – Get Rating) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, risk, earnings, profitability, valuation, dividends and institutional ownership. Analyst Ratings This is a summary of current ratings and target […] ....

United States , Fort Lauderdale , Potnetwork Holdings Inc , Sciences Get Rating , Foundation For Medical Education , Hologic Inc , Sciences Corporation , Get Rating , Exact Sciences , Given Exact Science , Exact Science , Network Holdings , Meds Biotech , Oncotype Test , Detect Test , Oncomap Extra , Medical Education , Exact Sciences Corporation , Otcmkts Potn , Stock Comparison , Stock Analysis ,

Analysts Anticipate Exact Sciences Co. (NASDAQ:EXAS) Will Announce Quarterly Sales of $461.86 Million

Analysts expect that Exact Sciences Co. (NASDAQ:EXAS – Get Rating) will post sales of $461.86 million for the current quarter, Zacks Investment Research reports. Seven analysts have made estimates for Exact Sciences’ earnings, with estimates ranging from $458.10 million to $466.90 million. Exact Sciences reported sales of $402.08 million during the same quarter last year, […] ....

United States , Jeffrey Thomas Elliott , Raymond James , Robertw Baird , Kevint Conroy , Securities Exchange Commission , Zacks Investment Research , Sciences Co , Commonwealth Equity Services , Ae Wealth Management , Asset Management One Co , Sohn Co , Wells Fargo Company , Sciences Get Rating , Sciences Corporation , Exact Sciences , Get Rating , Exact Science , Thomas Elliott , Exchange Commission , Equity Services , Investment Management , Asset Management One , Management One , Oncotype Test , Detect Test ,

Zacks: Brokerages Anticipate Exact Sciences Co. (NASDAQ:EXAS) Will Post Earnings of -$1.12 Per Share

Analysts expect Exact Sciences Co. (NASDAQ:EXAS – Get Rating) to announce ($1.12) earnings per share for the current quarter, according to Zacks. Seven analysts have issued estimates for Exact Sciences’ earnings, with the highest EPS estimate coming in at ($0.98) and the lowest estimate coming in at ($1.22). Exact Sciences posted earnings of ($0.18) per […] ....

United States , Jeffrey Thomas Elliott , Thomson Reuter , Raymond James , Sarah Condella , Banque Cantonale Vaudoise , Craig Hallum , Securities Exchange Commission , Zacks Investment Research , Sciences Co , Commonwealth Equity Services , Ae Wealth Management , Sohn Co , Wells Fargo Company , Goldman Sachs Group , Sciences Get Rating , Sciences Corporation , Exact Sciences , Get Rating , Exact Science , Wells Fargo , Exchange Commission , Thomas Elliott , Equity Services , Cantonale Vaudoise , Investment Management ,